| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |